Theme: (CME & CPD Credits Available)Advanced Insights in Cancer Therapeutics

Cancer Biology 2023

Renowned Speakers

Cancer Biology 2023


We cordially invite all dignitaries and sponsors from all over the world to the 21st International Conference on Cancer Biology and Cell Science, which will be held in Barcelona, Spain, April 5–6, 2023, with the theme "Advanced Insights in Cancer Therapeutics."

We warmly invite you to join us at Cancer Biology 2023, a venue where you can be sure that you'll interact with scientists from all around the world as needed.

Young researchers and scientists from all over the world would benefit from receiving a global platform to present their journals and views on the same Cancer Biology 2023 in front of eminent researchers, scientists, and academics. The Editorial Board Members and in the presence of our esteemed Organizing Committee Members demonstrated an unprecedented response and dynamic interest.


The 21st International Conference on Cancer Biology and Cell Science is set for April 05–06, 2023, in Barcelona, Spain. On behalf of the Scientific Organizing Committee, we are delighted to extend a warm invitation to all interested parties. With quick Keynote talks, Oral presentations, Poster presentations, Sponsor Ships, and Exhibitions, Cancer Biology 2023 welcomes all attendees from around the world.

This conference's theme is "Advanced Insights in Cancer Therapeutics." Cancer Biology 2023 is a two day event that includes a lettered scientific programme, loud able talks by the top notch of the international scientific community, and brings together active researchers, intellectuals, academicians, students, contributors, and industrialists to exchange ideas, communicate research findings, and discuss new advancements in all kinds of available cancer therapies worldwide innovative research products which can be exhibited for further development. By gathering all renowned oncologists under one roof, this Cancer Congress will be the biggest and most fruitful international conference that especially focuses on the Cell Science. This three-day multidisciplinary meeting will address all clinical and basic aspects of cancer therapies and cell science.


All oncologists, haematologists, research experts, and students working in this subject will find Cancer Biology 2023 to be the finest forum for exchanging knowledge regarding oncology research. In an effort to improve potency, precision, survivability, and quality of life, the principal biological method is being studied in this global event.

The Cancer Biology 2023 is the premier conference that brings together international experts, training institutes, pharmaceutical industries, manufacturing, business entrepreneurs, medical device companies, researchers, physicians, academicians, students, academic scientists, postdocs, industry professionals, and diagnostic laboratory professionals from all over the world to exchange knowledge, experience, and research innovations in order to develop cancer research scientists.

Cancer Biology 2023 is a unique conference created for oncologists and international medical health experts to promote the transmission and application of recent cancer research findings. The conference encourages participants from all top universities, clinical research organisations, and diagnostic enterprises to discuss their research experiences on every facet of this quickly expanding subject, offering a showcase of the newest methods.


Track:1 Cancer

The term "cancer" is broad. It explains the illness that develops as a result of unchecked cell growth and division brought on by cellular alterations. While certain cancer types cause cells to grow and divide more slowly than others, some cancer types promote fast cell growth. Tumours, which are visible growths, are the last stage of several cancers. The majority of cells in the body have definite roles and fixed lifespans. Apoptosis is a healthy and normal process that includes cell death. A cell is given the go-ahead to pass away so that the body can swap it out for a more advanced cell. Cancerous cells are deficient in the elements that tell healthy cells to stop proliferating and to die.

They consequently accumulate within the body, utilising the oxygen and nutrients.

Track:2 Types of Cancer & their Management

More than 100 different cancers exist. Typically, cancer types are called for the organs or tissues in which they first appear. For instance, brain cancer begins in the brain and lung cancer begins in the lung. The type of cell that gave rise to a cancer, such as an epithelial cell or a squamous cell, can also be used to describe the condition.

Track:3 Diagnosis & Screening of Cancer

Blood tests and biopsies are used to identify different types of cancer, but scans may also be required to monitor symptoms or evaluate the effectiveness of treatment. The testing will increasingly depend on the signs and type of cancer found in the sample.

People who are concerned that they have been diagnosed with a certain type of cancer can get thorough information on the many types of cancer. If people exhibit symptoms that a screening test would pick up as cancer, it would be determined whether cancer was the cause or not.

Track:4 Treatment of Cancer

There are numerous cancer therapy options available, each with a unique set of potential advantages, dangers, and adverse effects. People with slow-growing acute malignancies may be able to live with daily medication, but others with faster-growing slow-growing tumours may require more aggressive (intensive) therapies. Healthy stem cells are infused into the body during a stem cell transplant.

One of the anticancer medications that is used to obstruct and stop the growth of cancer cells in the body is chemotherapy. Radiation therapy kills cancer cells and relieves pain or discomfort. It might also be administered prior to a stem cell transplant.

Track:5 Clinical Trials of  Cancer

Clinical trials are merely the research projects created to assess tools, novel medications, and treatment modalities. Benefits and dangers are associated with all treatments, but participating in a clinical study can provide us a chance to take a more active role in our own healthcare. The earlier they are generally available, the more likely it is that innovative scientific therapies will be realised.

Track:6 Advanced Therapies in Cancer

·         Radiofrequency Ablation

·         Cryosurgical Ablation (CSA)

·         Cancer Microvascular Intervention (CMI)

·         Nano Knife Therapy

·         Photodynamic Therapy

·         Immunotherapy

·         Hyperthermia

·         Traditional Chinese Medicine

Track:7 Epidemiology of Cancer

Epidemiology is the study of factors that affect cancer, and it focuses on identifying likely patterns and causes. The concept of principle period predisposition holds that early diagnosis could falsely inflate a cancer's chances of survival while only slightly improving the infection's typical course.

When determining the cause of a tumour and identifying and developing improved drugs to improve the disease's usual course, epidemiological techniques are used in the investigation of malignancy. Long-term predisposition is the idea that screening tests will likely study slower-growing, more slothful cancers, but improvements in diagnosing more cases of slow disease may not translate into better patient outcomes following the implementation of screening programmes.

Track:8 Cancer Palliative Care & Survivors

Epidemiology, or how to infer likely trends and causes, is the study of factors that affect cancer. The concept of principle period predisposition holds that early detection may falsely inflate the chances of a cancerous growth surviving, without significantly increasing the infection's typical course.

The study of epidemiology as it relates to the examination of cancer uses epidemiological methods to identify the cause of the tumour as well as to identify and develop improved treatments that improve the disease's typical course. Long-term propensity holds that slower-growing, more sluggish cancers will likely be examined by screening tests, but improvements in diagnosing more cases of slow disease may not translate into better patient outcomes after the execution of screening programmes.

Track:9 Radiation Oncology

Radiation Oncology  (radiotherapy/radiation therapy) is a medical specialty that plays an important role in the multimodal treatment of cancer. It works by delivering high-energy x-rays (photons) through a linear accelerator. These painless and undetectable therapeutic x-rays are used to treat a variety of malignancies. The linear accelerator is located in a cancer centre, where a multidisciplinary team of radiation oncologists (your specialist doctor), nurses, radiation therapists, and medical physicists will discuss radiation therapy as a treatment option with you, assess you, plan and deliver your treatment, and assist you with any side effects.

Track:10 Bone Marrow Transplantation and Surgery

Haemopoietic stem cell transplants, sometimes referred to as bone marrow transplants, replace diseased bone marrow with healthy bone marrow stem cells. Spongy tissue makes up bone marrow. A biopsy could involve taking a sample of tissue from the body to examine it more thoroughly. If a preliminary examination reveals that a section of bodily tissue is abnormal, a biopsy should be advised. That patch of aberrant tissue may be referred to by doctors as a lesion, tumour, or mass. The scientific seminars cover topics such hematopoietic cell transplants, stem cell surgery, and bone marrow transplants.

Track:11 Hemato Immunology & Stem Cell Research

Blood groups are of the ABO type, however at the moment, there are 50 clearly defined antigens in the Rh blood grouping, of which 5 are more significant; these are D, C, E, and E. Rh factors are Rh positive and Rh negative, which relates to the D-antigen. These D-antigens aid in the avoidance of erythroblast fatality; the absence of Rh antigen is characterised as positive, but the presence of Rh antigen in the blood is defined as positive, which results in incompatibility. Haematology is the field that deals with cancer-related disease prevention and therapy. Clinical Immunology is the study of how the immune system responds to immune system disorders that cause hypersensitivity in patients with cancer, abnormal infection growth known as inflammation, and the emergence of an infection.

Track:12Cancer Genomics & Metabolomics

A branch of genomics called oncogenomics studies the characteristics of genes that are connected to or associated with cancer. It mainly focuses on transcript, epigenomic, and genomic changes in cancer. Oncogenomics' major goal is to identify new oncogenes or tumour suppressor genes that could open up new avenues for study into cancer diagnosis, cancer prognosis, and potential new targets for cancer treatments. Targeted cancer medicines like Gleevec, Herceptin, and Avastin have made it possible for oncogenomics to identify novel cancer therapeutic targets. The term "metabolomics" refers to the entire range of small-molecule metabolites, which allows for the systematic analysis of distinct chemical fingerprints that leave cellular activities in the dust. It is a relatively young topic of "omics" research. The collection is represented by the metabolome.

Track:13 Anaemia and Blood Disorders

When your blood lacks enough solid red platelets or haemoglobin, you may experience weakness. A crucial component of red platelets that binds oxygen is haemoglobin. The cells in your body won't get enough oxygen if you have abnormally few or fascinating red platelets, irregularly low or low haemoglobin, or any of these conditions.

Regularly, mild iron deficiency has no negative effects. Exhaustion, fair skin, and shortness of breath with effort can result from more severe pallor. Pallor of inadequate press: The body needs iron to produce red platelets. The most frequently accepted causes of press insufficiency paleness are low iron intake and blood loss due to the feminine cycle.

Normal blood problems include pallor, draining disorders, such as haemophilia, leukaemia, lymphoma, and myeloma.

Track:14 Cell-Based Therapy

To improve the immune system's capacity to combat cancer, cellular treatments are used. In order to create them, a patient must first remove a chosen group of blood cells, change the cells to provide a more ferocious attack on the cancer cells, and then reintroduce the modified cells into the patient.

In order to treat illnesses and fight disease, cell-based therapy includes altering the patient's own cells or donor cells. We have recently contributed to the development of chimeric antigen receptor therapy, a revolutionary cell-based strategy for the treatment of blood malignancies. We continue to look into a growing variety of cell types for potential new therapeutic applications.

Track:15 Advancement in the field of cancer

In most nations, cancer is a growing factor in morbidity and mortality. In the media, "breakthroughs" in cancer research are frequently publicised. Some stories are backed by recent findings that offer hope for better therapies, but others are hasty or motivated by publicity, making their intentions murky. The public has great hopes that basic cancer research will lead to better cancer treatments and care. However, there is limited knowledge and comprehension of clinical trials, which are crucial in determining the efficacy of cutting-edge medicines. Recruitment to randomised clinical trials investigating novel cancer therapies is frequently slow, in part due to people's conviction that all novel therapies are probably better than the current standard of care and in part due to their discomfort with the randomization procedure.

Track:16 Chemical Biology

Cancer is an increasing cause of morbidity and mortality in the majority of countries. "Breakthroughs" in cancer research are routinely reported in the media. While some stories are supported by current research and provide promise for new therapies, others are rushed or driven by publicity, leaving their motivations unclear. The general public has high expectations that fundamental research on cancer would improve cancer treatments and care. Clinical trials, which are essential for establishing the effectiveness of cutting-edge medications, are, nevertheless, poorly understood and understood in a limited way. Because of people's opinion that all novel therapies are likely superior to the present standard of care and their discomfort with the randomization, recruitment to randomised clinical trials examining novel cancer therapies is usually slow.

Track:17 Computational Oncology

The genomes of both healthy and malignant cells have been the subject of an astounding amount of data collection thanks to next-generation sequencing. Our researchers are developing computational oncology tools to help them navigate and interpret this enormous amount of data and turn molecular discoveries into patient-beneficial treatments.

A relatively new term in medicine that is starting to acquire traction is computational oncology. Some people might be surprised to learn that huge medical institutions all over the world are creating complete departments labelled as such.

Track:18 Epigenetics

The term "epigenetics" describes inherited knowledge that is transmitted from parent cell to daughter cell but is not encoded in the DNA sequence. While certain epigenetic alterations are a normal component of numerous biological processes, other kinds can cause disease, including cancer.

Without changing the DNA sequence, changes in gene expression result from chemical modifications of a cell's genetic material. In the recent years, scientists have discovered that epigenetic pathways are crucial to the initiation, growth, and advancement of many cancer forms. Contrary to genetic mutations, epigenetic states are frequently reversible, suggesting that medications may be used to modify them in order to obstruct the actions of cells that promote tumour growth.

Track:19 Cancer Health Disparities

Over the past few decades, there has been significant progress in cancer treatment, screening, diagnosis, and prevention; however, there has not been equal progress in addressing cancer health disparities, which include higher cancer death rates, less frequent use of effective screening tests, and higher rates of advanced cancer diagnoses in some populations.

People from poor socioeconomic classes, particular racial/ethnic populations, and residents of remote places regularly experience these discrepancies.


The market size for cancer treatments was $98,900 million in 2018 and is projected to grow to $180,193 million by 2026, with a CAGR of 7.7% from 2019 to 2026. Chemotherapy and other oncology medications are administered as part of cancer treatments to treat cancer.

The three main drivers of the expansion of the cancer therapies market are an increase in the prevalence of cancer, an increase in pharmaceutical companies' cooperation, and an increase in cancer research. The ageing population is also anticipated to expand, which will accelerate market expansion.

However, the high development costs for oncology drugs and the unfavourable side effects of cancer therapies are some of the issues limiting market expansion. 

Key Benefits for the Cancer Therapeutics Industry:

 The research includes a strategic assessment of the global cancer therapeutics market along with a complete quantitative analysis of the cancer therapeutics market from 2018 to 2026 to identify the current opportunities.

Market estimates and size are based on in-depth examinations of the most popular medications, applications, and market changes.

A thorough regional study helps to comprehend the local market and facilitates strategic company planning.

To comprehend the market's competitive environment, the development methods used by the major players are listed. 


To network

A big reason for attending the conference is to meet with likeminded people and industry peers. This conference brings together people from all different geographical areas who share a common discipline or field, and they are a great way to meet new people in your field.

To expand your knowledge and find solutions to problems

You'll learn a lot of new information about topics in your area. These could include learning from thought leaders you may not have previously heard of, as well as brand-new methods, tools, and data.

 To present your ideas and work to others

One of the more obvious justifications for going to a conference to present your work is this. Talking about what you do with a range of people from comparable, relevant, and/or completely unrelated fields of study is good practise.


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date April 05-06, 2023
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View